Search

KPV is a synthetic tripeptide corresponding to the C-terminal fragment (lysine-proline-valine) of alpha-melanocyte-stimulating hormone, studied for anti-inflammatory activity. It is not FDA-approved and has no published human efficacy randomized controlled trials; evidence is preclinical, with animal and cell models examining gut and skin inflammation. It is investigated as an anti-inflammatory research peptide.